Cargando…
Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models
Recent research highlights the key role of iron dyshomeostasis in the pathogenesis of prostate cancer (PCa). PCa cells are heavily dependent on bioavailable iron, which frequently results in the reprogramming of iron uptake and storage pathways. Although advanced-stage PCa is currently incurable, bi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607736/ https://www.ncbi.nlm.nih.gov/pubmed/37894914 http://dx.doi.org/10.3390/ijms242015231 |
_version_ | 1785127612357541888 |
---|---|
author | Currie, Crawford Bjerknes, Christian Myklebust, Tor Åge Framroze, Bomi |
author_facet | Currie, Crawford Bjerknes, Christian Myklebust, Tor Åge Framroze, Bomi |
author_sort | Currie, Crawford |
collection | PubMed |
description | Recent research highlights the key role of iron dyshomeostasis in the pathogenesis of prostate cancer (PCa). PCa cells are heavily dependent on bioavailable iron, which frequently results in the reprogramming of iron uptake and storage pathways. Although advanced-stage PCa is currently incurable, bioactive peptides capable of modulating key iron-regulatory genes may constitute a means of exploiting a metabolic adaptation necessary for tumor growth. Recent annual increases in PCa incidence have been reported, highlighting the urgent need for novel treatments. We examined the ability of LNCaP, PC3, VCaP, and VCaP-EnzR cells to form colonies in the presence of androgen receptor inhibitors (ARI) and a series of iron-gene modulating oligopeptides (FT-001-FT-008). The viability of colonies following treatment was determined with clonogenic assays, and the expression levels of FTH1 (ferritin heavy chain 1) and TFRC (transferrin receptor) were determined with quantitative polymerase chain reaction (PCR). Peptides and ARIs combined significantly reduced PCa cell growth across all phenotypes, of which two peptides were the most effective. Colony growth suppression generally correlated with the magnitude of concurrent increases in FTH1 and decreases in TFRC expression for all cells. The results of this study provide preliminary insight into a novel approach at targeting iron dysmetabolism and sensitizing PCa cells to established cancer treatments. |
format | Online Article Text |
id | pubmed-10607736 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106077362023-10-28 Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models Currie, Crawford Bjerknes, Christian Myklebust, Tor Åge Framroze, Bomi Int J Mol Sci Article Recent research highlights the key role of iron dyshomeostasis in the pathogenesis of prostate cancer (PCa). PCa cells are heavily dependent on bioavailable iron, which frequently results in the reprogramming of iron uptake and storage pathways. Although advanced-stage PCa is currently incurable, bioactive peptides capable of modulating key iron-regulatory genes may constitute a means of exploiting a metabolic adaptation necessary for tumor growth. Recent annual increases in PCa incidence have been reported, highlighting the urgent need for novel treatments. We examined the ability of LNCaP, PC3, VCaP, and VCaP-EnzR cells to form colonies in the presence of androgen receptor inhibitors (ARI) and a series of iron-gene modulating oligopeptides (FT-001-FT-008). The viability of colonies following treatment was determined with clonogenic assays, and the expression levels of FTH1 (ferritin heavy chain 1) and TFRC (transferrin receptor) were determined with quantitative polymerase chain reaction (PCR). Peptides and ARIs combined significantly reduced PCa cell growth across all phenotypes, of which two peptides were the most effective. Colony growth suppression generally correlated with the magnitude of concurrent increases in FTH1 and decreases in TFRC expression for all cells. The results of this study provide preliminary insight into a novel approach at targeting iron dysmetabolism and sensitizing PCa cells to established cancer treatments. MDPI 2023-10-16 /pmc/articles/PMC10607736/ /pubmed/37894914 http://dx.doi.org/10.3390/ijms242015231 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Currie, Crawford Bjerknes, Christian Myklebust, Tor Åge Framroze, Bomi Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models |
title | Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models |
title_full | Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models |
title_fullStr | Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models |
title_full_unstemmed | Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models |
title_short | Assessing the Potential of Small Peptides for Altering Expression Levels of the Iron-Regulatory Genes FTH1 and TFRC and Enhancing Androgen Receptor Inhibitor Activity in In Vitro Prostate Cancer Models |
title_sort | assessing the potential of small peptides for altering expression levels of the iron-regulatory genes fth1 and tfrc and enhancing androgen receptor inhibitor activity in in vitro prostate cancer models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607736/ https://www.ncbi.nlm.nih.gov/pubmed/37894914 http://dx.doi.org/10.3390/ijms242015231 |
work_keys_str_mv | AT curriecrawford assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels AT bjerkneschristian assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels AT myklebusttorage assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels AT framrozebomi assessingthepotentialofsmallpeptidesforalteringexpressionlevelsoftheironregulatorygenesfth1andtfrcandenhancingandrogenreceptorinhibitoractivityininvitroprostatecancermodels |